Sargentini-Maier ML - Search Results

1

Pharmacokinetics, Safety, and Tolerability of Brivaracetam in Healthy Elderly Participants.

Stockis A, Nicolas JM, Sargentini-Maier ML, Krauwinkel W. Stockis A, et al. Among authors: sargentini maier ml. Clin Pharmacol Drug Dev. 2023 Nov;12(11):1121-1127. doi: 10.1002/cpdd.1264. Epub 2023 May 22. Clin Pharmacol Drug Dev. 2023. PMID: 37212183

2

Brivaracetam disposition in renal impairment.

Sargentini-Maier ML, Sokalski A, Boulanger P, Jacobs T, Stockis A. Sargentini-Maier ML, et al. J Clin Pharmacol. 2012 Dec;52(12):1927-33. doi: 10.1177/0091270011431457. Epub 2012 Jan 10. J Clin Pharmacol. 2012. PMID: 22235139 Clinical Trial.

3

Brivaracetam disposition in mild to severe hepatic impairment.

Stockis A, Sargentini-Maier ML, Horsmans Y. Stockis A, et al. Among authors: sargentini maier ml. J Clin Pharmacol. 2013 Jun;53(6):633-41. doi: 10.1002/jcph.82. Epub 2013 May 3. J Clin Pharmacol. 2013. PMID: 23649964 Clinical Trial.

4

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after single increasing oral doses in healthy males.

Sargentini-Maier ML, Rolan P, Connell J, Tytgat D, Jacobs T, Pigeolet E, Riethuisen JM, Stockis A. Sargentini-Maier ML, et al. Br J Clin Pharmacol. 2007 Jun;63(6):680-8. doi: 10.1111/j.1365-2125.2006.02829.x. Epub 2007 Jan 12. Br J Clin Pharmacol. 2007. PMID: 17223857 Free PMC article. Clinical Trial.

5

Population pharmacokinetics of levetiracetam in Japanese and Western adults.

Pigeolet E, Jacqmin P, Sargentini-Maier ML, Stockis A. Pigeolet E, et al. Clin Pharmacokinet. 2007;46(6):503-12. doi: 10.2165/00003088-200746060-00004. Clin Pharmacokinet. 2007. PMID: 17518509

6

Pharmacokinetics and metabolism of 14C-brivaracetam, a novel SV2A ligand, in healthy subjects.

Sargentini-Maier ML, Espié P, Coquette A, Stockis A. Sargentini-Maier ML, et al. Drug Metab Dispos. 2008 Jan;36(1):36-45. doi: 10.1124/dmd.107.017129. Epub 2007 Oct 1. Drug Metab Dispos. 2008. PMID: 17908923

7

The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men.

Rolan P, Sargentini-Maier ML, Pigeolet E, Stockis A. Rolan P, et al. Br J Clin Pharmacol. 2008 Jul;66(1):71-5. doi: 10.1111/j.1365-2125.2008.03158.x. Epub 2008 Mar 13. Br J Clin Pharmacol. 2008. PMID: 18341673 Free PMC article. Clinical Trial.

8

Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration.

Stockis A, Sargentini-Maier ML, Brodie MJ. Stockis A, et al. Among authors: sargentini maier ml. Epilepsy Res. 2016 Dec;128:163-168. doi: 10.1016/j.eplepsyres.2016.11.001. Epub 2016 Nov 9. Epilepsy Res. 2016. PMID: 27842261 Clinical Trial.

9

Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.

Toublanc N, Sargentini-Maier ML, Lacroix B, Jacqmin P, Stockis A. Toublanc N, et al. Clin Pharmacokinet. 2008;47(5):333-41. doi: 10.2165/00003088-200847050-00004. Clin Pharmacokinet. 2008. PMID: 18399714

10

Assessment of levetiracetam bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy: Open-label, single-dose, randomized, four-way crossover study in healthy male volunteers.

Stockis A, Sargentini-Maier ML, Otoul C, Connor A, Wilding I, Wray H. Stockis A, et al. Among authors: sargentini maier ml. Clin Ther. 2010 Sep;32(10):1813-21. doi: 10.1016/j.clinthera.2010.09.001. Clin Ther. 2010. PMID: 21194605 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page